U.S. Logistics Stock News

BrightView Holdings (BV) has moved to extend the maturity of its senior secured term loans from April 2029 to June 2033, and is also lengthening its receivables financing facility to June 2029. See our latest analysis for BrightView Holdings. BrightView Holdings’ recent debt maturity extensions come as the stock trades at $14.27, with a 30-day share price return of 15.45% and a 90-day share price return of 21.03%, yet a 1-year total shareholder return that declined 14.29%. This suggests...

On 27 June 2026, Brixmor Property Group Inc. was removed from the Russell 1000 Dynamic Index, prompting index-tracking funds to adjust their positions. This index removal matters because forced buying and selling by rules-based investors can reshape who owns the stock and how it trades over time. With Brixmor’s exit from the Russell 1000 Dynamic Index now in the past, we’ll explore how this change may influence its investment narrative. The best AI stocks today may lie beyond giants like...

Index removals put TIC Solutions in the spotlight TIC Solutions (TIC) has been removed from several Russell indices, including the Russell 2000, 3000, and 2500 growth and defensive benchmarks. This change can influence both trading flows and investor attention. See our latest analysis for TIC Solutions. TIC Solutions has seen mixed momentum, with the share price up 25.99% over the past 90 days but the year to date share price return down 16.18%, and the 1 year total shareholder return down...

The FDA’s new PreCheck pilot is putting fresh attention on U.S. biopharmaceutical manufacturing stocks, as faster facility reviews could reshape how quickly companies bring complex therapies to market. With select facilities from Eli Lilly, Regeneron and others lined up for accelerated oversight, investors are watching which businesses might gain from quicker approvals, added capacity and stronger onshore supply chains, and which could be left waiting. This article walks through 3 stocks from...

Why the QUELL-CV Trial Matters for BioAge Labs Stock BioAge Labs (BIOA) has moved its lead drug candidate, BGE-102, into the Phase 2 QUELL-CV trial, a randomized, placebo-controlled study targeting cardiovascular risk in adults with obesity and elevated inflammation. The trial plans to enroll about 160 participants over 12 weeks of once daily dosing, testing three oral dose levels against placebo. The primary focus is change in high-sensitivity C-reactive protein, with additional inflammatory...

Index additions put fresh focus on Resideo Technologies Resideo Technologies (REZI) has been added to several Russell growth indices, including the Russell 2500 Growth and Russell 3000 Growth benchmarks, an event that can influence how index-tracking investors view the stock. See our latest analysis for Resideo Technologies. At a share price of US$30.96, Resideo Technologies has seen shorter term momentum soften, with the 90 day share price return down 8.16% and the year to date share price...

Recently, Savara announced that the US FDA accepted its biologics license application for MOLBREEVI for autoimmune pulmonary alveolar proteinosis, assigning a PDUFA target action date of November 22, while CFO David Lowrance exercised 580,187 stock options and sold 394,528 shares. This regulatory milestone and executive share activity highlight both the advancing path toward a potential first-in-class therapy and how insiders are managing their equity exposure at a key moment for the...

With inflation trends shifting, oil prices easing and central banks weighing their next moves, many investors are looking for income streams that feel steadier than short term market headlines. That is where the Dividend Powerhouses screener comes in, focusing on companies with dividend yields above 5% that are covered, growing and relatively stable. In a world of mixed growth signals from the US, Europe and Asia, reliable cash distributions can be a useful anchor for a portfolio. Below,...

National HealthCare (NYSEAM:NHC) has been added to multiple prominent Russell growth indices. This index inclusion reflects Russell’s latest rebalancing and adjusts National HealthCare’s place in key growth benchmarks. The move may affect how institutional investors view and access the stock. National HealthCare enters these Russell growth indices with a recent share price of $206.54 and a reported 3-year return of 263.5%. The stock has also logged a 95.7% return over the past year and is...

Investors were disappointed with Oracle Corporation's ( NYSE:ORCL ) earnings, despite the strong profit numbers. We...

Political tensions around the proposed Save America Act and questions about US institutional strength are back in focus, and that can rattle even seasoned investors. While headlines debate strongman politics and the resilience of courts, media, and the military, some investors are looking again at US blue-chip defensive stocks that may be better suited to handle sharper mood swings in markets. This article walks through 3 stocks from our US Blue-Chip Defensive Stocks screener that appear...

The Supreme Court’s decision to allow more time for counting mail-in ballots has pushed election rules back into the spotlight, and a handful of stocks are closely tied to how those rules are applied on the ground. When voting procedures feel more settled, attention can shift to the companies that help run elections, verify identities, and process ballots. This article looks at three stocks from the Election Technology and Services screener that are directly exposed to the latest mail-in...

American Homes 4 Rent (AMH) drew investor attention after its recent share move, with the stock closing at $34.09 as performance over the past month and past 3 months stood out in sector comparisons. See our latest analysis for American Homes 4 Rent. Looking beyond the latest move, American Homes 4 Rent has shown firm momentum, with a 90-day share price return of 22.10% and a year-to-date share price return of 6.80%, while the 1-year total shareholder return declined 1.62%. If this recent...

Recent price move puts PennyMac Financial Services in focus PennyMac Financial Services (PFSI) moved higher in the latest session, with the stock up 2.1% on the day and 7.9% over the past week. The move has drawn fresh attention from income and mortgage sector investors. See our latest analysis for PennyMac Financial Services. Looking beyond this week, PennyMac Financial Services shows a mixed picture, with the share price up 2.6% over 30 days but down 34.5% year to date, while the 5 year...

The latest cost cutting plan at British American Tobacco, including 9,000 global job cuts and a push toward more digital and AI focused operations, is a reminder that even mature tobacco companies can face sharp shifts in how they run and spend. For investors watching Consumer Defensive stocks, that kind of restructuring can change risk, cash flow priorities, and appetite for nicotine alternatives. This article looks at 3 stocks from our Tobacco & Nicotine Alternatives screener that appear...

On 27 June 2026, Diversified Healthcare Trust (NasdaqGS:DHC) was removed from several Russell indices, including the Russell 3000E, Russell 3000E Value, Russell Microcap, and Russell Microcap Value benchmarks. This broad index exclusion can alter who holds the stock and how it trades, as index-tracking funds and some institutions adjust their portfolios. Next, we examine how DHC’s removal from multiple Russell indices interacts with its existing investment narrative and risk profile. This...

HBT Financial has recently been highlighted as a compelling dividend-focused investment, supported by a payout ratio of 35% and an average annual dividend growth rate of 7.62% over the past five years. Investor attention has also centered on consensus expectations for a 17.06% increase in earnings per share for 2026, which reinforces the perception that the company may have room to continue supporting its dividend profile. We will now examine how HBT Financial’s projected earnings growth...

Over the last 7 days, the United States market has experienced a 2.5% drop, yet it remains up by 19% over the past year with earnings forecasted to grow by 18% annually. In this dynamic environment, identifying high growth tech stocks involves looking for companies that demonstrate strong potential for revenue expansion and innovation while aligning with broader market trends.

Over the last 7 days, the United States market has experienced a 2.5% decline, although it has risen by 19% over the past year, with earnings projected to grow by 18% annually in the coming years. In this climate of fluctuating performance and optimistic earnings forecasts, identifying stocks that are potentially undervalued can offer opportunities for investors seeking to capitalize on possible discounts.

Over the last 7 days, the United States market has experienced a 2.5% drop, though it has risen by 19% over the past year with earnings projected to grow by 18% annually. In this context, growth companies with high insider ownership can be particularly appealing as they often signal confidence from those closest to the business in its potential for future success.

Over the last 7 days, the United States market has dropped 2.5%, although it remains up by 19% over the past year and earnings are forecast to grow annually by 18%. Despite being considered a somewhat outdated term, penny stocks still offer intriguing investment opportunities, especially when they involve smaller or newer companies with solid financials. In this article, we examine three promising penny stocks that combine balance sheet strength with potential for significant growth, offering...

Over the last 7 days, the United States market has experienced a 2.5% decline, yet it remains up by 19% over the past year with earnings forecast to grow by 18% annually. In light of these conditions, identifying dividend stocks that offer stable returns and potential for growth can be an effective strategy for investors seeking reliable income streams.

Why Martin Marietta Materials is on investors’ radar today Martin Marietta Materials (MLM) recently drew attention after its share price closed at $616.06, leaving some investors reassessing what the current valuation and recent return profile might imply for the stock. See our latest analysis for Martin Marietta Materials. While the latest 1 day share price return of -2.05% is a setback, Martin Marietta Materials still shows a 30 day share price return of 5.92%, alongside a 1 year total...

In late June 2026, Compass Minerals International, Inc. (NYSE:CMP) was removed from multiple Russell Value and Small Cap benchmarks, including the Russell 2000 and Russell 3000 Value indices, following the latest index reconstitution. This broad removal from Russell indices can influence demand for CMP shares because index-tracking funds may adjust their holdings, potentially affecting liquidity and how investors view the company’s role in value and small-cap portfolios. We’ll now examine...